









Earnhardt Lisa D - Insider Stock Trading - OpenInsider











Sector

All Sectors

Group by Sector


Aerospace
Agriculture
Automobile
Building
Business Services
Chemical
Electrical
Energy
Fashion
Financial
Food & Beverage
Fund
Healthcare
Household
Insurance
Machinery
Media
Metals
Mining
Other
Personal Services
Real Estate
Retail
Technology
Telecom
Transportation
Utility




Industry

All Industries

Group by Industry






Insiders
Filings


All
Purchases
Sales

CIK: 1530893 - Address: C/o Intersect Ent, Inc., 1555 Adams Drive, Menlo Park, CA 94025 30 results 

						Links
						


SECYahooGoogleFinvizTradingViewStockChartsStockTwitsDownload CSV 













TC
Stat
Stk
Ins
Fil
+d
+w
+m
+q
+h
+y
avg


S%ret1118-1-1-3-9-17-35-11S%wins836747608010073 




Filing Date
T Date
Ticker
IssuerInc Sector
IndIndustry
Owner
oSt
Rel
Title
T
TVal
Price
L
Qty
oc
Own
H
r2y
r1y
r6m
r3m
r6w
r3w
r7d
r3d
f1d
f1w
f1m
f3m
f6m
f1y



7/18/17 17:507/17/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d121.200102587D
7/18/17 17:507/17/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-58129.030-20-3587D
6/19/17 16:426/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d121.200102597D
6/19/17 16:426/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-52226.100-20-3597D
5/16/17 17:165/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d121.2011102607D-28889733531-4-5
5/16/17 17:165/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-46022.9811-20-3607D-28889733531-4-5
4/18/17 17:594/17/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d121.203102617D-37-1112419-42346
4/18/17 17:594/17/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-32116.063-20-3617D-37-1112419-42346
3/16/17 19:143/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d121.203102627D-33-1154117241113-22
3/16/17 19:143/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-30015.023-20-3627D-33-1154117241113-22
2/17/17 18:302/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d241.203203637D-43-29-1048-120-3024
2/17/17 18:302/15/17XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-26013.013-20-3637D-43-29-1048-120-3024
10/19/16 20:0410/17/16XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d01.20400583D7-12-81011775-1-2-25-238
10/19/16 20:0410/17/16XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-718.004-00583D7-12-81011775-1-2-25-238
4/19/16 16:344/15/16XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.dm291.204244583D-25234946-20-34-20-13
4/19/16 16:344/15/16XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.dm-53318.694-29-5583D-25234946-20-34-20-13
3/16/16 19:463/15/16XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-16218.014-9-2588D-25-33-13-5-5-7-2-409-14-11-7
1/20/16 17:401/15/16XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOM.d101.20781597D-18-38-3-9-16-610-115-13-28
1/20/16 17:401/15/16XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS.d-24119.267-13-2597D-18-38-3-9-16-610-115-13-28
12/16/15 19:0512/15/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-13519.855-7-1601D4-32-23-72-3-4-35-6-20-30-45
11/17/15 10:5711/16/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-12318.0011-7-1608D2-25-40-12-19-106122-30-30
10/16/15 16:0510/15/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-12818.7214-7-1615D19-27-39-24-9-700-10-8-30-15
9/16/15 10:059/15/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-17725.997-7-1622D629-12-141230-7-29-23-35-43
8/19/15 10:278/17/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-19428.519-7-1628D8730256086-2-15-10-40-38-51
7/16/15 18:377/15/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-57229.6211-19-3635D30151655213-10-43-41-59
6/16/15 09:536/15/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-56629.3012-19-3654D54271226840-11-12-32-51
5/19/15 13:375/15/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOP,CEOS-45823.695-19-3674D359-2-435-3-51915-28-50
4/17/15 12:564/15/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOSee RemaS-50225.964-19-3693D6274330-10-919-30-29
3/18/15 13:103/16/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOSee RemaS-45523.566-19-3712D4919120-3-1-1610259-29
2/19/15 14:122/17/15XENTIntersect Ent, Inc.DEHealthMdEqSurgical & Medical InstrumentEarnhardt Lisa DCADOSee RemaS-43822.693-19-3732D443014682032430-20



DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing



S - SaleSale of securities on an exchange or to another person

S - Sale+OESale of securities on an exchange or to another person (after option exercise)

F - TaxPayment of exercise price or tax liability using portion of securities received from the company

P - PurchasePurchase of securities on an exchange or from another person


Return to top
Contact
Copyright © 2017 OpenInsider.com. All rights reserved.




Lisa D. Earnhardt, Pres., Cardiac Surgery, Boston Scientific Corp.














A publisher of Business Information since 1983   
  





 


   

Search Business Search Executive 
  Advanced Search 




  

Sign In  |  Hints 









Profile of Lisa Earnhardt 





 


Lisa Earnhardt

 

Pres., Cardiac Surgery - Boston Scientific Corp.

 


Lisa Earnhardt Email :
Please login 

 

Company Name : 
Boston Scientific Corp. 

 

Company Website : 
www.bostonscientific.com 

 

Company Address : 
One Boston Scientific Pl., Natick, MA,United States, 


 


Lisa Earnhardt Profile :
Pres., Cardiac Surgery - Boston Scientific Corp. 

 


Lisa Earnhardt Biography :


Lisa Earnhardt is President, Cardiac Surgery at Boston Scientific Corporation.Prior to this role, Lisa held a variety of sales and marketing positions of increasing responsibility within Guidant Corporation's Cardiac Rhythm Management (CRM) and Cardiac Surgery (CS) divisions, including CRM Marketing Manager for Tachy, CRM Regional Manager, CS National Sales Director, and CS Director of Marketing. Most recently, she was CS Vice President of Sales and Marketing and General Manager, Revascularization.Prior to joining Guidant, Lisa worked at Dell in New Product Operations. She began her career at APM/CSC Healthcare in San Francisco, where she provided strategic and operational consulting services to healthcare provider organizations.Lisa holds a M.B.A. from Northwestern's Kellogg School of Management, where she serves on the advisory board, and a B.S. in Industrial Engineering from Stanford University. 

 


Lisa Earnhardt Colleagues :





Name 
Title 
Email 


Peter Nicholas 
Co - Founder, Chmn. 
Please login 


N. Nicholas 
Board Dir. 
Please login 


Uwe Reinhardt 
Board Dir. 
Please login 


Marye Anne Fox 
Board Dir. 
Please login 


John Pepper 
Board Dir. 
Please login 













            Home  |  About Us  |  Product Information   |  Subscription  |  List Builder   |  Executive List   |  Email Lists   |  Contact Us  |  Site Map  |  Browse Directory    





 

© 2009, Walkers's Research - A publisher of Business Information since 1983, All Rights Reserved.



    Lisa Earnhardt | Intersect ENT Inc | ZoomInfo.com


Insider Trading - Earnhardt Lisa D - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Earnhardt Lisa D





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Common stock purchase or sale:



TransactionDate
ReportedDate
Company
Symbol
InsiderRelationship
SharesTraded
AveragePrice
TotalAmount
SharesOwned
Filing




2016-10-17Sale
2016-10-198:04 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
400
$18
$7,200
557,268(IndirectDirect)
View


2016-04-15Sale
2016-04-194:34 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
28,500
$18.69
$532,588
581,368(IndirectDirect)
View


2016-03-15Sale
2016-03-167:46 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
9,000
$18.01
$162,084
561,368(IndirectDirect)
View


2016-01-15Sale
2016-01-205:40 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
12,500
$19.26
$240,808
582,868(IndirectDirect)
View


2015-12-15Sale
2015-12-167:05 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
6,820
$19.85
$135,408
574,868(IndirectDirect)
View


2015-11-16Sale
2015-11-1710:57 am
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
6,818
$18
$122,732
581,688(IndirectDirect)
View


2015-10-15Sale
2015-10-164:05 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
6,818
$18.72
$127,619
588,506(IndirectDirect)
View


2015-09-15Sale
2015-09-1610:05 am
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
6,818
$25.99
$177,229
595,324(IndirectDirect)
View


2015-08-17Sale
2015-08-1910:27 am
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
6,818
$28.51
$194,385
602,142(IndirectDirect)
View


2015-07-15Sale
2015-07-166:37 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
19,318
$29.62
$572,153
608,960(IndirectDirect)
View


2015-06-15Sale
2015-06-1609:53 am
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
19,318
$29.3
$565,992
628,278(IndirectDirect)
View


2015-05-15Sale
2015-05-191:37 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
19,318
$23.69
$457,628
647,596(IndirectDirect)
View


2015-04-15Sale
2015-04-1712:56 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DSee RemarksDirector
19,318
$25.96
$501,544
666,914(IndirectDirect)
View


2015-03-16Sale
2015-03-181:10 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DSee RemarksDirector
19,318
$23.56
$455,057
686,232(IndirectDirect)
View


2015-02-17Sale
2015-02-192:12 pm
Intersect Ent Inc.
XENT
Earnhardt Lisa DSee RemarksDirector
19,318
$22.69
$438,343
705,550(IndirectDirect)
View




Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-17Exercise
2016-10-198:04 pm
N/AN/A
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
400
$1.2
557,268(Direct)
View


2016-10-17Exercise
2016-10-198:04 pm
N/A2023-04-22
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
400
$1.2
557,268(Direct)
View


2016-05-18Option Award
2016-05-205:26 pm
N/A2026-05-18
Nevro Corp
NVRO
Earnhardt Lisa DDirector
3,240
$63.39
3,240(Direct)
View


2016-04-15Exercise
2016-04-194:34 pm
N/AN/A
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
20,000
$1.2
581,368(Direct)
View


2016-04-15Exercise
2016-04-194:34 pm
N/AN/A
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
4,000
$1.2
581,368(Direct)
View


2016-04-15Exercise
2016-04-194:34 pm
N/A2023-04-22
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
20,000
$1.2
581,368(Direct)
View


2016-04-15Exercise
2016-04-194:34 pm
N/A2023-04-22
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
4,000
$1.2
581,368(Direct)
View


2016-01-15Exercise
2016-01-205:40 pm
N/AN/A
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
8,000
$1.2
582,868(Direct)
View


2016-01-15Exercise
2016-01-205:40 pm
N/A2023-04-22
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
8,000
$1.2
582,868(Direct)
View


2016-01-15Option Award
2016-01-205:40 pm
N/A2026-01-14
Intersect Ent Inc.
XENT
Earnhardt Lisa DPresident and CEODirector
225,000
$18.9
582,868(Direct)
View


2015-06-29Option Award
2015-07-015:34 pm
N/A2025-06-29
Nevro Corp
NVRO
Earnhardt Lisa DDirector
5,853
$53.59
5,853(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 10:33:04 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Lisa D. Earnhardt: Executive Profile & Biography - Bloomberg









































  





















































































July 28, 2017 11:33 AM ET
Pharmaceuticals

Company Overview of Intersect ENT, Inc.



SnapshotPeople 




OverviewBoard MembersCommittees



Executive Profile
Lisa D. Earnhardt  Chief Executive Officer, President and Director, Intersect ENT, Inc.AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 4 different industries.See Board Relationships47$2,772,825As of Fiscal Year 2016
Background

		Ms. Lisa D. Earnhardt has been the Chief Executive Officer and President of Intersect ENT, Inc. since March 2008. Ms. Earnhardt serves as the Chief Executive Officer and President of Sinexus, Inc. She served as the President of Cardiac Surgery of Boston Scientific Corp. Prior to this role, she held a variety of sales and marketing positions of increasing responsibility within Guidant Corporation's Cardiac Rhythm Management (CRM) and Cardiac Surgery (CS) divisions, including ... CRM Marketing Manager for Tachy, CRM Regional Manager, CS National Sales Director and CS Director of Marketing. She served as a CS Vice President of Sales and Marketing and General Manager of Revascularization. Prior to joining Guidant, she worked at Dell in New Product Operations. She began her career at APM/CSC Healthcare in San Francisco, where she provided strategic and operational consulting services to healthcare provider organizations. She has been a Director of Intersect ENT, Inc. since March 2008 and Nevro Corp. since June 29, 2015. She served as a Director of Nerites Corporation and Kensey Nash Corporation from September 19, 2011 to June 22, 2012. Ms. Earnhardt holds an MBA from Northwestern's Kellogg School of Management, where she serves on the Advisory Board and a BS in Industrial Engineering from Stanford University.Read Full Background




Corporate Headquarters
1555 Adams DriveMenlo Park, California 94025United StatesPhone: 650-641-2100Fax: --
Board Members Memberships
2008-PresentChief Executive Officer, President and DirectorIntersect ENT, Inc.2015-PresentDirectorNevro Corp.
Education
BS Stanford UniversityMBA J.L. Kellogg School of Management, Northwestern University
Other Affiliations
Stanford UniversityBoston Scientific CorporationKensey Nash CorporationJ.L. Kellogg School of Management, Northwestern UniversityNerites CorporationNevro Corp.


Annual Compensation
Salary$523,551Total Annual Compensation$523,551
Stocks Options
All Other Compensation$2,030Exercisable Options$324,787Unexercisable Options$251,562Total Number of Options$576,349
Total Compensation
Total Annual Cash Compensation$911,569Total Short Term Compensation$523,551Other Long Term Compensation$2,030Total Calculated Compensation$2,772,825




Request Profile Update
















 












The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking 
	here.




Stock Quotes


Market data is delayed at least 15 minutes.







Company Lookup



COMPETITOR COMPENSATIONNamePosition/CompanyCompensationOmar S. Ishrak Chairman & CEOMedtronic plc$1.5MKevin A. Lobo Chairman and Chief Executive OfficerStryker Corporation$1.1MOlivier  Bohuon Chief Executive Officer and DirectorSmith & Nephew plc$2.5MAlex  Gorsky Chairman & CEOJohnson & Johnson$1.6MHiroyuki  Sasa President & Representative DirectorOlympus Corporation$102.4MCompensation as of Fiscal Year 2016.










Sponsored Financial Commentaries

Sponsored Links






Browse Companies
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 | 
0
1
2
3
4
5
6
7
8
9






Request Profile Update

						Only a company representative may request an update for the company profile. Documentation will be required.
					  
To contact Intersect ENT, Inc., please visit .  Company data is provided by S&P Global Market Intelligence.  Please use this form to report any data issues.
					  


Information Missing - Please enter your information in the following field(s): 




Company Name

Your Name*

Your E-Mail Address*

Your Phone Number*

Type of Data*


Overview
Executives
Key developments
Similar companies
Transactions


Update Needed*

All data changes require verification from public sources.  Please include the correct value or values and a source where we can verify.


Cancel


Submit






Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.


Close




























D. Earnhardt  Lisa - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











D. Earnhardt  Lisa
Check out list of companies and businesses related to D. Earnhardt  Lisa. Find out D. Earnhardt  Lisa address and contact details. View other people related to D. Earnhardt  Lisa - coworkers, colleagues, companions, etc.
Address:   

c/o Intersect ENT, Inc. 1555 Adams Drive Menlo Park 94025 CA




Companies related to D. Earnhardt  Lisa
CIKCompany NamePositionCompany Address0001271214Intersect ENT, Inc.1555 ADAMS DRIVE  MENLO PARK 94025




D. Earnhardt  Lisa on the Web
Persons related to D. Earnhardt  Lisa - Intersect ENT, Inc.NamePositionCityRick D  AndersonDirector AUSTINRick D  AndersonDirector AUSTINRick D  Anderson10% Owner AUSTINRobert H  Binney JrVice President, Sales MENLO PARKRobert H  Binney JrVice President, Sales MENLO PARKGWEN R.  CARSCADDENChief People Officer MENLO PARKTansey  CaseyMenlo Parkde Clercq  CasperPalo AltoMatthew S  CrawfordAUSTINMatthew S  CrawfordAUSTINJeffrey  CrowePALO ALTOMead, Jr.  DanaMenlo ParkClercq Casper L.  deDirector PALO ALTOLisa  EarnhardtPresident and CEO EXTONLisa D  EarnhardtSee Remarks MENLO PARKLisa D  EarnhardtPresident and CEO MENLO PARKMelrose  EvanAustinIRWIN  FEDERMANMENLO PARKMark J  FletcherDirector MINNEAPOLISMark J  FletcherMINNEAPOLISMoll  FredericPalo AltoMoll  FredericMenlo ParkKieran  GallahueDirector POWAY CAPROMOD  HAQUEPALO ALTOJERYL L  HILLEMANChief Financial Officer SANTA CLARAJERYL L  HILLEMANChief Financial Officer MENLO PARKMatthew D.  HowardPALO ALTORichard E  KaufmanSr VP& Chief Operating Officer MENLO PARKRichard E  KaufmanSVP & Chief Operating Officer MENLO PARKKLEINER PERKINS CAUFIELD & BYERS XI-A LP10% Owner MENLO PARKKLEINER PERKINS CAUFIELD & BYERS XI B LPMENLO PARKKPCB XI Associates, LLCMENLO PARKSTEVEN M  KRAUSZSUNNYVALESTEVEN M  KRAUSZMENLO PARKDavid Aaron  LehmanGeneral Counsel PLEASANTONDAVID E  LIDDLEMENLO PARKDAVID E  LIDDLEMENLO PARKEarnhardt  LisaPalo AltoEarnhardt  LisaMenlo ParkCynthia L  Lucchese PLEASANTONCynthia L  LuccheseDirector MENLO PARKFletcher  MarkMinneapolisPaul A  MatteucciMENLO PARKChas  McKhannChief Commercial Officer MENLO PARKDANA G  MEAD JRDirector INDIANAPOLISDana G Jr.  MeadDirector MENLO PARKDana G Jr.  MeadDirector MENLO PARKFREDERIC H  MOLLDirector MOUNTAIN VIEWFREDERIC H  MOLLDirector MENLO PARKDe Martini  MonikaPalo AltoDe Martini  MonikaMenlo ParkNorwest Venture Partners XI, LP10% Owner PALO ALTONorwest Venture Partners XII, LPPALO ALTOPinto Technology Ventures GP II, L.P.AUSTINPinto Technology Ventures GP II, L.P.AUSTINPinto TV GP CO LLCAUSTINPinto TV GP CO LLCAUSTINPresidio Management Group IX, L.L.C.10% Owner MENLO PARKPTV SCIENCES II L P10% Owner AUSTINPTV SCIENCES II L P10% Owner AUSTINKaufman  RichardPalo AltoKaufman  RichardMenlo ParkAnderson  RickAustinJONATHAN D  ROOTMENLO PARKJames  StambaughVP Clinical Affairs MENLO PARKJames  StambaughVP, Clinical and Reimbursement MENLO PARKJames  StambaughVP Clinical Affairs & Reimb. MENLO PARKSusan P  StimsonMENLO PARKSusan P  StimsonVice President, Marketing MENLO PARKCasey M  TanseyDirector MENLO PARKU S Venture Partners IX L PMENLO PARKW ANTHONY  VERNONDirector SAN FRANCISCOAmy  WolbeckV.P. Regulatory Affairs & Qlty MENLO PARKAmy  WolbeckVP, Reg. Affairs and Quality MENLO PARKPHILIP M  YOUNGMENLO PARK




Other people with surname EarnhardtEarnhardt  Roger, Earnhardt  Jonathan, Earnhardt  Jonathan








 









Microsoft personalized ad preferences




 













To opt out of personalized ads in this browser, your browser history must allow first-party and third-party cookies and you must have your browsing experience set to NOT delete browsing history on exit. Instructions for enabling cookies and configuring your browsing history may be available in your browsers settings, privacy, or help documentation.

















Sign in
















  Hold on… We’re sorry but this didn’t work.                  You can’t turn off personalized ads right now because your browser is currently blocking third-party cookies. We can help you fix this issue.                Let’s get started:  Depending on what browser you use, open Options or Settings.                  Make sure that third-party cookies are not blocked anymore. To find out how, search your browser’s Help.                                 Revisit http://choice.microsoft.com/opt-out, and then on the “Personalized ads in this browser” tile, click Off.                 ext74081 




  About Our Ads To create a more customized online experience, some of the ads you may receive on Microsoft websites and apps are tailored to your previous activities, searches and site visits. You're in control and here's where you can make the advertising choice that's right for you. ext74075 




  Where Can I Learn More about Advertising on Microsoft Websites and Apps? Microsoft partners with Oath, AppNexus and other third party service providers to help present customized content and display advertisements on MSN, Outlook.com and other websites and apps. Microsoft also delivers search ads to Bing and our search syndication partners. Learn more about Microsoft’s privacy practices here. You can learn more about interest-based ads from Oath and AppNexus in their privacy statements: Oath and AppNexus. What Choices Do I Have About Interest-Based Advertising? On this page, you can opt out of receiving interest based advertising from Microsoft. You can also opt out of receiving interest-based advertising from all self-regulatory members, including Microsoft, Oath, AppNexus and other third party ad networks, at the following sites:  In the US: Digital Advertising Alliance (DAA) In Europe: European Interactive Digital Advertising Alliance (EDAA) In Canada: Ad Choices: Digital Advertising Alliance of Canada (DAAC)  You can control interest-based advertising in Windows apps by turning off the advertising ID in Windows Settings.  More choices  Do you want personalized ads from other companies?  Questions? If you have a privacy question or a question for the Chief Privacy Officer of Microsoft, please contact us by using our web form. We will respond to questions within 30 days. ext74076 




       Personalized ads in this browser     OFF    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting for this web browser.  Learn more           If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.          ext74078 




       Personalized ads wherever I use my Microsoft account     OFF   Sign in to change...    Opt-out is currently unavailable, please try again later.  Control the "personalized ads" setting that applies when you are signed in on any computer or device with your Microsoft account, including Windows, Windows phone, Xbox and other devices.  Learn more                    If you want Microsoft to show ads that might be relevant to you, click On. To show “generic” ads, click Off.         If you choose “generic” ads and use a browser, your choice applies to everyone when using that browser as long as you do not clear your cookies.          ext74079 




       Personalized ads in Windows         In your Windows Settings, you can turn off personalized ads that appear in apps on this device. You’ll still see ads, but they won’t be personalized anymore.     If you have Windows 8.1:            Access the charms by touching or moving your pointer to the right edge of the screen.                 Click or tap Settings, and then click or tap Change PC Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have Windows 10:            Click or tap the Start button.                 Click or tap Settings.                 Click or tap Privacy, and then turn off Let apps use my advertising ID for experiences across apps.          If you have a Windows mobile device:            Go to Settings.                 Tap on Privacy.                 Tap on Advertising ID, and then turn off Let apps use my advertising ID for experiences across apps.                If you want to turn off personalized ads from Microsoft wherever you use your Microsoft account including apps on Windows, Windows Phone, Xbox and other devices, you can do so by selecting the Microsoft account option above.    ext74080 














Legal
Privacy & Cookies
© 2017 Microsoft












President and CEO of Intersect ENT (NASDAQ:XENT), Earnhardt Lisa D, sells 20,000 shares worth 0,642









































Stay Connected

Latest Posts in RSS

BusinessEntertainmentFeatured NewsFeatured Press ReleaseFinanceHealthLifestyleNationNon FirstPageOriginalPress ReleaseReviewShoppingSportsStocksTechnologyTravelWorld


Latest Comments in RSS


 / 













EmpoweredNews
World News Summary Helping You Stay Informed









Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping




Our Writers
About Us
Privacy Policy
Contact Us
Advertise
Press Releases
















President and CEO of Intersect ENT (NASDAQ:XENT), Earnhardt Lisa D, sells 20,000 shares worth $580,642
According to Intersect ENT's most recent Form 4 filing with the SEC dated Jul 18 05:50 PM, company President and CEO, Earnhardt Lisa D disclosed selling 20,000 shares at a cost of $29.03. At the time of this transaction (Jul 17), this trade was worth $580,642 in total. As of Jul 17, Earnhardt Lisa D now owns 560,868 shares in total worth about $16,293,215.4. 
For the last few recent trades made by Intersect ENT (NASDAQ:XENT) President and CEO, Earnhardt Lisa D, we have the following information:




SEC Form 4 filing: Oct 17: Sold 400 shares at the rate of $18.00 per share. Total worth of this trade was $7,200. Total number of shares owned as of Oct 17 were 556,868




					Posted by  



George Daniels 

					
					on Tuesday July 18 2017, 7:46 PM EDT. 

All trademarks acknowledged. 
Filed under Stocks.

	Comments closed, Trackbacks open.	
 Follow responses: 
RSS 2.0




Comments are closed


 Latest News 
Pres., Int. Lead Markets & CRO of McDonald’s Corporation (NYSE:MCD), Goare Douglas M, sells 17,286 shares worth $2,739,831
Exec Vice Pres & CFO of McDonald’s Corporation (NYSE:MCD), Ozan Kevin M, sells 25,322 shares worth $4,013,537
EVP, Gen Counsel and Secretary of McDonald’s Corporation (NYSE:MCD), Krulewitch Jerome N, sells 11,755 shares worth $1,861,757
VP-Controller of Badger Meter (NYSE:BMI), Smiley Beverly L P, sells 9,911 shares worth $447,972
Member of 10% owner group. of Ormat Technologies (NYSE:ORA), Bronicki Investments Ltd., sells 3,323,431 shares worth $189,435,567
President & CEO of Sarepta Therapeutics (NASDAQ:SRPT), Ingram Douglas S, buys 47,058 shares worth $1,999,965
Director of Northwest Bancshares (NASDAQ:NWBI), Tredway Philip M, sells 13,560 shares worth $218,667
President of County Bancorp (NASDAQ:ICBK), Schneider Timothy J., sells 543 shares worth $13,575
CEO & Chairman of Opko Health (NASDAQ:OPK), Frost Phillip Md Et Al, buys 23,600 shares worth $149,687
Director of Bryn Mawr Bank Corporation (NASDAQ:BMTC), Gilbert Andrea F, sells 1,775 shares worth $78,264

 


News Categories 
Business (7)

Stocks (15,604)



Entertainment (1,297)

Featured News (3,486)

Featured Press Release (254,233)

Finance (309)

Health (653)

Lifestyle (19)

Nation (90)

Non FirstPage (2)

Original (47)

Press Release (17)

Review (1)

Shopping (267)

Sports (613)

Technology (194)

Travel (286)

World (1,367)


  Featured Press Releases 
Pres., Int. Lead Markets & CRO of McDonald’s Corporation (NYSE:MCD), Goare Douglas M, sells 17,286 shares worth $2,739,831
Exec Vice Pres & CFO of McDonald’s Corporation (NYSE:MCD), Ozan Kevin M, sells 25,322 shares worth $4,013,537
Sanitary Napkins Market Opportunities And Analysis Of Top Key Player Forecasts To 2022
Milk Packaging 2017 Global Market Expected to Grow at CAGR 3.35% and Forecast to 2020
Sports Nutrition  2017 Global Market Key Players – Glanbia, NBTY, Abbott Laboratories, GNC Holdings, MuscleTech, Cellucor, MusclePharm, Universal Nutrition, Gaspari Nutrition-Analysis And Forecast To 2022
Global Rain Detector Market by Manufacturers, Regions, Type and Application, Forecast to 2022
Global Airport Display Systems Market by Manufacturers, Regions, Type and Application, Forecast to 2022
Global Turbocompressor Market by Manufacturers, Regions, Type and Application, Forecast to 2022
Global Retinal Camera Market 2017 Key Players, Share, Supply, Demand, Growth, Application, Analysis and Forecast to 2022
Cancer Immunotherapies 2017 Global Market Expected to Grow at CAGR 15.17% and Forecast to 2020







Business
Finance
Sports
Entertainment
Health
Technology
Travel
Shopping
 

About Us
Contact Us
Privacy Policy
Advertise
Press Releases
Terms Of Service
 
Log in 















XENT Lisa D. Earnhardt Insider Trades for Intersect ENT Inc.


































Bulletin






Investor Alert







New York Markets Close in:



Market Snapshot
Winners and Losers


















Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close






Expand
Keep Open
Close































Intersect ENT Inc.

                  NASDAQ: XENT
          



GO



Set Alerts
Find a Broker




Join TD Ameritrade




Market Index


 

Overview
      
Profile
      
News
      
Charts
      
Financials
      
Historical Quotes
      
Analyst Estimates
      
Options
      
SEC Filings
      
Insiders
      


/marketstate/country/us

Intersect ENT Inc.



Market open
 --Real time quotes
Jul 28, 2017, 11:29 a.m.


XENT

/quotes/zigman/35526436/composite


$
27.25




Change

-0.05
-0.18%

Volume
Volume 57,784
Real time quotes








/quotes/zigman/35526436/composite
Previous close

$
			27.30
		


$
				27.25
			
Change

-0.05
-0.18%





Day low
Day high
$26.95
$27.40










52 week low
52 week high

            $7.65
        

            $29.55
        


















Insider Activity


Individual




Lisa D. Earnhardt



Ms. Lisa D. Earnhardt is President, Chief Executive Officer & Director at Intersect ENT, Inc. and a Member at Young Presidents' Organization, Inc. She is on the Board of Directors at Nevro Corp. and Intersect ENT, Inc. 
Ms. Earnhardt was previously employed as Independent Director by Kensey Nash Corp., President-Cardiac Surgery Division by Boston Scientific Corp., and Vice President-Sales & Marketing by Guidant Corp. She also served on the board at Nerites Corp. 
She received her undergraduate degree from Stanford University and an MBA from Kellogg School of Management.



Transactions


Date
Shares
Transaction
Value





07/17/2017
20,000


 
Disposition at $29.03 per share.


580,600


07/17/2017
10,000


 
Derivative/Non-derivative trans. at $1.2 per share.


12,000


06/15/2017
20,000


 
Disposition at $26.1 per share.


522,000


06/15/2017
7,375


 
Derivative/Non-derivative trans. at $1.2 per share.


8,850


06/15/2017
2,625


 
Derivative/Non-derivative trans. at $1.2 per share.


3,150


05/15/2017
20,000


 
Disposition at $22.98 per share.


459,600


05/15/2017
10,000


 
Derivative/Non-derivative trans. at $1.2 per share.


12,000


04/17/2017
20,000


 
Disposition at $16.06 per share.


321,200


04/17/2017
10,000


 
Derivative/Non-derivative trans. at $1.2 per share.


12,000


03/15/2017
10,000


 
Disposition at $15.02 per share.


150,200


03/15/2017
10,000


 
Disposition at $15.03 per share.


150,300


03/15/2017
10,000


 
Derivative/Non-derivative trans. at $1.2 per share.


12,000


02/15/2017
20,000


 
Disposition at $13.01 per share.


260,200


02/15/2017
20,000


 
Derivative/Non-derivative trans. at $1.2 per share.


24,000


01/18/2017
54,000


 
Award at $0 per share.


0


10/17/2016
400


 
Disposition at $18 per share.


7,200


10/17/2016
400


 
Derivative/Non-derivative trans. at $1.2 per share.


480


04/18/2016
8,500


 
Disposition at $19.5 per share.


165,750


04/18/2016
4,000


 
Derivative/Non-derivative trans. at $1.2 per share.


4,800


04/15/2016
20,000


 
Disposition at $18.34 per share.


366,800


04/15/2016
20,000


 
Derivative/Non-derivative trans. at $1.2 per share.


24,000


03/15/2016
9,000


 
Disposition at $18.01 per share.


162,090


01/15/2016
12,500


 
Disposition at $19.26 per share.


240,750


01/15/2016
8,000


 
Derivative/Non-derivative trans. at $1.2 per share.


9,600


12/15/2015
6,820


 
Disposition at $19.85 per share.


135,377


11/16/2015
6,818


 
Disposition at $18 per share.


122,724


10/15/2015
6,818


 
Disposition at $18.72 per share.


127,633


09/15/2015
6,818


 
Disposition at $25.99 per share.


177,200


08/17/2015
6,818


 
Disposition at $28.51 per share.


194,382


07/15/2015
19,318


 
Disposition at $29.62 per share.


572,200


06/15/2015
19,318


 
Disposition at $29.3 per share.


566,018


05/15/2015
19,318


 
Disposition at $23.69 per share.


457,644


04/15/2015
19,318


 
Disposition at $25.96 per share.


501,496


03/16/2015
19,318


 
Disposition at $23.56 per share.


455,133


02/17/2015
19,318


 
Disposition at $22.69 per share.


438,326





        Copyright 2017 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
    











            Officers and Executives
        





Ms. Lisa D. Earnhardt 
President, Chief Executive Officer & Director




Mr. Richard E. Kaufman 
COO, Senior VP-Research & Development




Ms. Jeryl L. Hilleman 
Chief Financial Officer




Mr. James W. Stambaugh 
Vice President-Clinical Affairs




Ms. Susan P. Stimson 
Vice President-Marketing & International




Mr. Robert H. Binney 
Vice President-Sales




Ms. Nicole  Osmer 
Head-Media Relations




Ms. Gwen R. Carscadden 
Chief People Officer




Mr. David A. Lehman 
Secretary & General Counsel




Ms. Amy Conuel Wolbeck 
Vice President-Regulatory Affairs & Quality




Ms. Cynthia L. Lucchese 
Independent Director




Mr. Dana G. Mead 
Independent Director




Mr. Kieran T. Gallahue 
Lead Independent Director




Mr. William Anthony Vernon 
Independent Director




Dr. Frederic H. Moll 
Independent Director









Trending Tickers


/quotes/zigman/17636479/composite VUZI+15.60%


/quotes/zigman/237947/composite JCP-5.83%


/quotes/zigman/59392505/composite NUGT-2.93%


/quotes/zigman/59386294/composite JNUG-5.94%


/quotes/zigman/65801738/composite TLT+1.11%


X




Powered by














Log In




11:33 AM EDT
July 28, 2017


/marketstate/country/us
New York

	Open


/marketstate/country/uk
London

	Open


/marketstate/country/jp
Tokyo

	Closed





/marketstate/country/us
 


/marketstate/country/uk
 


/marketstate/country/jp
 











View All



Latest News

/news/latest
11:27aWhat is an ICO?
11:22aOne way you’re paying credit-card fees, even if you don’t have a card
11:18aStock market edges lower, on track for weekly losses 
11:18aOil sets sights on biggest weekly gain of the year
11:16aUPDATE: Invisalign maker Align stocks surge 8% after earnings blow past estimates
11:12aAirbus to sell plant holdings to Motorola
11:11aAmerican Airlines profit falls, unit revenue gains
11:11aChevron swings to profit as charges shrink
11:11aSears Canada's biggest shareholders call off bid
11:10aRedfin's stock debuts 30% above its IPO price
11:10aTime for GOP to face reality: Everybody is going to have health insurance
11:09aBP earnings: What to expect
11:09aExxon, Chevron post strong profits 
11:08aChina penalizes nine banks for forex violations
11:06aRedfin's stock opens at $19.56, or 30% above $15 IPO price
11:03aEurope’s refugee crisis won’t be solved in a distant court
11:01aWhat Trump could do to make Obamacare ‘implode’
10:58aFoxconn’s history of broken promises casts a shadow on Wisconsin news
10:56aHere’s something that can improve your memory — and help you sleep
10:56a$1 million or $5,000 a month: which would you choose?
Loading more headlines...




dow

/quotes/zigman/627449/realtime
21,779.09

-17.46
-0.08%





nasdaq

/quotes/zigman/12633936/realtime
6,361.73

-20.46
-0.32%





s&p 500

/quotes/zigman/3870025/realtime
2,467.81

-7.61
-0.31%













Kiosk


1352872800000
1352872800000


The RetireMentors






				Retirement advice from our industry experts
				Our team of financial professionals can help you plan and save 
					for retirement, then 
				live well in it.



/conga/kiosk/retirementors.html
361307




1320411600000
1320616500000


Alerts



/conga/kiosk/alerts.html
310238




1333717800000
1333964100000


Virtual Stock Exchange





Our free stock-market game
				• Trade your virtual portfolio in real time
				• Talk strategies in group discussions
				• Find or create a game that suits you
				• Use our learning center to improve 



/conga/kiosk/games.html
310284




1245657600000
1277280000000


Location Scouts




Housing-market insights from our realty pros
																																																							Plus the latest data from Realtor.com on 21 home markets across the U.S.
• See our complete Real Estate site


/conga/kiosk/real_estate.html
357012




1404799200000
1404799200000


Lazy Portfolios





				Set it and forget it
				Check out the returns on our 8 Lazy Portfolios that are made up 
				of low-cost 
				buy-and-hold index funds.

				• How to create your own Lazy Portfolio


/conga/kiosk/lazy_portfolio.html
313134














MarketWatch.com




Site Index
Topics
Help
Feedback
Newsroom Roster

                    Media Archive
Premium Products
Mobile


Company Info
Code of Conduct
Corrections
Advertising Media Kit
Advertise Locally
Reprints & Licensing
Broker Center

                    Your Ad Choices


Follow MarketWatch


































RSS
Podcasts






WSJ.com
Barron's Online
BigCharts
Virtual Stock Exchange


Financial News London
WSJ.com Small Business
realtor.com
Mansion Global












		Copyright © 2017 MarketWatch, Inc.  All rights reserved.
		By using this site, you agree to the Terms of Service,
        Privacy Policy and Cookie Policy.
	



            Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.
        






MarketWatch Top Stories
Link to MarketWatch's Slice.

15






















































